Honda revealed the next-generation Fit subcompact in Japan on Friday. Photo credit: Honda.
Will Honda's (NYSE: HMC ) new Fit build on the old car's success?
The car was revealed this past week in Japan. It's a prototype of the all-new Honda Fit. The new Fit is due to be rolled out in Japan this fall, and it will be here in the U.S. by next summer.
Stylistically, it's ... well, let's say it's a departure from the outgoing model, which has won many fans with its endearing looks. In a way, the current Fit is a lot like Hondas of old: light, simple, well thought out.
The new Fit might not have the visual appeal of the old one. But at least in its hybrid incarnation, it has something else: record-breaking fuel economy.
The new Fit Hybrid is amazing, and not coming to the U.S.
Honda says the hybrid version of the new Fit will get 36.4 kilometers from each liter of gas in the standard fuel-economy test the Japanese government uses. That translates to about 84 miles per gallon -- good enough to make it Japan's most fuel-efficient car.
Best Dow Dividend Stocks For 2015: Questcor Pharmaceuticals Inc.(QCOR)
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides prescription drugs for the treatment of auto-immune diseases. The company?s primary product is H.P. Acthar Gel (repository corticotropin injection), an injectable drug for the treatment of acute exacerbations of multiple sclerosis; infantile spasms in infants and children under two years of age; nephrotic syndrome; and Lupus. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California.
Advisors' Opinion:- [By Shauna O'Brien]
Goldman Sachs reported on Tuesday that it has started coverage on Questcor Pharmaceuticals Inc (QCOR).
The firm has initiated coverage on QCOR with a “Neutral” rating and $71 price target. This price target suggests a 8% upside from the stock’s current price of $65.27.
An analyst from the firm noted: “We are confident in the continued growth of Acthar by expanding further in new indications, and we believe the deal for Synacthen helped ensure the sustainability of the franchise and removed a key overhang on the stock.”
“However, given the recent very strong run in the stock and the current valuation, we’re taking a more cautious stance on risk/reward for being an aggressive buyer here. We think there are a number of factors that could cause some downward volatility in the stock, and we would be opportunistic and look for a better entry point,” added the analyst.
Questcor Pharmaceuticals shares were mostly flat during pre-market trading Tuesday. The stock is up 144% YTD.
- [By Keith Speights]
Acthar gel boasts 19 different indications for which the Food and Drug Administration has granted approval. Questcor (NASDAQ: QCOR ) now has its sights on profiting from one of those that it hasn't targeted previously. The company today announced plans to kick off a pilot commercialization effort for�symptomatic sarcoidosis, a rare disease that most often affects the lungs.
- [By Louis Navellier]
New prescriptions for Subsys, a drug used to alleviate breakthrough pain for cancer patients, was the leading reason for the excellent performance. The company has a strong pipeline as well and expects to file at least New Drug Application and at least four Investigational New Drug applications in 2014. Portfolio Grader upgraded the stock back in August and this biotechnology stock is still a strong buy based on the superior fundamental.
Biotech Stocks to Buy: Questcor Pharmaceuticals (QCOR)Questcor Pharmaceuticals (QCOR) makes drugs that help patients with serious medical problems. Most of their sales are from Acthar an injectable drug used in 19 indications. Most of the revenues are derived from patients with adults with multiple sclerosis and children under 2 who suffer from infantile spasms. The drug is also approved for the treatment of lupus erythematosus.
- [By Seth Jayson]
Questcor Pharmaceuticals (Nasdaq: QCOR ) reported earnings on April 30. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Questcor Pharmaceuticals whiffed on revenues and whiffed on earnings per share.
Top 10 Japanese Companies To Watch In Right Now: Alibaba Group Holding Ltd (BABA)
Alibaba Group Holding Limited, incorporated on June 28, 1999, is an online and mobile commerce company. The Company operates its ecosystem as a platform for third parties. The Company operates Taobao Marketplace, China�� online shopping destination, Tmall, China�� third-party platform for brands and retailers and Juhuasuan, China�� group buying marketplace. In addition to its three China retail marketplaces, the Company operates Alibaba.com, China�� global online wholesale marketplace, 1688.com, its China wholesale marketplace, and AliExpress, its global consumer marketplace, as well as provides cloud computing services. As a platform, the Company provides the fundamental technology infrastructure and marketing reach to help businesses leverage the power of the Internet to establish an online presence and conduct commerce with consumers and businesses. Effective August 01, 2014, Alibaba Investment Ltd, a unit of Alibaba Group Holding Ltd, acquired a 10.193% interest n Singapore Post Ltd.
The buyers and sellers discover, select and transact with each other on the Company�� platform. Third-party service providers add value to its platform through service offerings that make it easier for buyers and sellers to do business. The third-party participants in its ecosystem include a payment services provider, logistics providers, retail operational partners, marketing affiliates, independent software vendors and various professional service providers. The Company has developed policies and procedures that maintain the health and sustainability of its marketplaces, including consumer protection programs, marketplace rules, qualification standards for merchants and buyer and seller rating systems. As its ecosystem expands, new jobs are created.
Taobao Affiliate Network is powered by Alimama, its online marketing technology platform. Through this platform, sellers place marketing displays on its marketing affiliates��websites and mobile apps, and sellers pay a performance-b! ased marketing fee primarily based on cost-per-click (CPC), and cost-per-sale (CPS), models. Through China Smart Logistics, the Company provides real-time information to its logistics partners, including key operating metrics, such as distribution center utilization rates, route planning data and order volume forecasts. Independent software vendors (ISVs) provide software tools, as well as systems integration services to sellers.
Tmall is an online platform featuring brands and retailers with each seller having an identifiable online storefront. Users may access Tmall anytime, anywhere through the Tmall Website and the mobile apps and mobile-optimized websites provided by Taobao Marketplace and Tmall. The physical product categories on Tmall include apparel and accessories, electronics and appliances, home furnishings, home appliances, maternity and baby products. Juhuasuan is an online group buying marketplace in China. Juhuasuan offers quality products at discounted prices by aggregating demand from numerous consumers. Juhuasuan mainly does this through flash sales, which make products available at discounted prices for a limited period of time. Juhuasuan offers group buying channels featuring branded and private label products, products made to custom specifications and local services.
AliExpress is a consumer marketplace enables consumers from around the world to buy directly from wholesalers and manufacturers in China. On AliExpress, consumers have access to a variety of products. In addition to the global English-language site, AliExpress operates two local language sites in Russia and Brazil. The product categories on AliExpress.com include apparel and accessories, phones and communications products, beauty and health, computer networking, jewelry and watches. Alibaba.com is an online commerce platform. Sellers on Alibaba.com may pay for an annual Gold Supplier membership to host a premium storefront with product listings on the marketplace.
The Company��! marketin! g technology platform, Alimama, offers sellers on its marketplaces marketing services for both personal computer and mobile devices, which include P4P marketing service and display marketing. Alimama also offers its sellers these marketing services through third parties through the Taobao Affiliate Network. The Taobao Ad Network and Exchange (TANX) automates the buying and selling of billions of advertising impressions on a daily basis by third parties. The Company also offer a data management platform (DMP), connected to TANX. Its DMP allows participants on TANX to evaluate and select online advertising inventory using both behavioral data they provide, as well as data from browsing behavior and shopping history. Its Cloud Computing supports its commerce ecosystem by providing a distributed computing infrastructure to handle the large volume of traffic and data generated on its online marketplaces. Its cloud computing platform offers service offerings, including elastic computing, database services and storage and large scale computing services.
The company offer search functions on all of its Web pages, mobile apps and many of its marketing affiliates��websites and apps to make it easy for buyers to find products and services within its marketplaces. The Company offers Aliwangwang, a personal computer-based instant messenger that supports text, audio and video communication. The Company developed Aliwangwang to facilitate open communication between buyers and sellers on Taobao Marketplace and Tmall. Buyers and sellers use it as a tool for a range of tasks, including negotiation of prices, customer services and delivery notification, in addition to the basic messaging functions. It offer Qianniu , an integrated platform for communication and productivity tools which allows sellers on Taobao Marketplace and Tmall to manage their operations more efficiently.
Alipay, the Company�� related company, provides payment and escrow services for transactions on Taobao Marketplace, Tm! all, 1688! .com and certain of its other sites, as well as to third parties in China. The Company�� small and medium enterprise (SME) loan business provides micro loans to sellers on its wholesale and retail marketplaces through lending vehicles licensed by the local government.
The company competes with Tencent and Baidu.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
ChinaFotoPress/Getty ImagesEmployees cheer at Alibaba headquartes in China as its stock debuts in New York. At $231 billion, Alibaba Group (BABA) closed Friday with more than twice the market cap of Facebook (FB), three times that of eBay (EBAY), and about 50 percent more than Amazon.com (AMZN). For founder Jack Ma, the run-up means he's now worth more than $20 billion, according to Forbes' estimates. Yahoo (YHOO), meanwhile, is now sitting on a stake that was worth more than $49 billion the day of the initial public offiering -- about $10 billion more than its current market cap.
- [By MONEYMORNING.COM]
Alibaba Group Holding Ltd. (NYSE: BABA) stock will be priced on Thursday (Sept. 18) evening, in what could be the largest initial public offering of all time.
- [By Sophia Yan]
Ma's remaining 7.8% stake in the company is estimated to be worth about $13 billion. The deal values Alibaba (BABA) itself at $163 billion, slightly bigger than Amazon (AMZN, Tech30).
- [By WWW.DAILYFINANCE.COM]
Mark Lennihan/APJack Ma is the founder of Alibaba. There has been no shortage of debutantes on Wall Street lately. Dozens of companies went public last quarter -- many of them names you know, or that you will know soon. These some of the more intriguing initial public offerings to come out of this past quarter. El Pollo Loco (LOCO) Fast casual has been the place to be for investing in the restaurant industry, and that helped pave the way for this California-based chain specializing in citrus-marinated chicken to go public in July at $15 a share. Investors won't be impressed by its slow yet calculated expansion. It had grown from 398 locations to just 401 in the year leading up to its IPO. However, El Pollo Loco's store-level performance has been impressive. It posted a 5.4 percent increase in comparable-restaurant sales in its first quarter as a public company. That is certainly better than the average fast-food or casual-dining chain out there, once again validating the fast-casual model, where chains offer the convenience of fast food but the quality of traditional casual-dining restaurants. Mobileye (MBLY) The push to develop self-driving cars is really getting traction, a fact that became even more apparent last week when Tesla (TSLA) showed off an updated sedan that uses a dozen sensors to do everything from adjusting speed in accordance with speed limit signs when it's on cruise control to switching lanes automatically when the sensors see an opening in traffic after the driver triggers the turn signal. But clever sensors notwithstanding, self-driving cars won't happen without serious software, and that's where Mobileye comes in. The Israeli company provides software and chips for camera-based advanced driver assistance systems. This will likely become a competitive market in the future, but for now Mobileye is seen as a leading pioneer in self-driving vehicles. Its share price has roughly doubled since it went public at $25 just two months ago. Re
Top 10 Japanese Companies To Watch In Right Now: Frontier Beverage Company Inc (FBEC)
Frontier Beverage Company, Inc., incorporated on November 18, 2002, is in the business of development, marketing and distribution of New Age/Alternative Beverages and snack products. New Age/Alternative Beverages is an industry categorization for a group of products that include energy drinks/infused water, fruit juices and drinks, dairy and dairy substitutes, and bottled/canned teas. In October 2013, the Company announced that it has acquired holding company 22 Social Club Productions Inc. and its subsidiaries Blue 22 Entertainment.
The Company markets, sells and maintain inventories of Innovative Beverage Group Holdings, Inc. known as UnWind Ultimate Relaxation (UnWind) in Citrus Orange, Goji Grape and Pom Berry flavors in cases of twelve, 12-ounce slim cans. In addition to 12-ounce cans of UnWind, the Company also developed and test marketed a product line known as Bulldozer, which was a concentrated version of the canned UnWind beverage packaged in three-ounce containers. The Company's point-of-sale line includes posters, statics, info cards, suction racks and suction stickers.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Frontier Beverage Company Inc (OTCMKTS: FBEC), IMD Companies Inc (OTCMKTS: ICBU) and Dmh International Incorporated (OTCBB: DMHI) were all mimicking the Titanic last Friday by sinking 41.18%, 32.5% and 28.16%, respectively, last Friday. Moreover, all three of these stocks have been the subject of paid promotions or investor relation campaigns. With the promotions in mind, is it to late to dump these small cap stocks or will this week present a buying opportunity? Here is a closer look:
Frontier Beverage Company Inc (OTCMKTS: FBEC) Announces Changes and Proposed PlansSmall cap Frontier Beverage Company is a diversified holding company with the following subsidiaries: 22 Social Club Productions, Blue 22 Entertainment and App Quest LLC. On Friday, Frontier Beverage Company sank 41.18% to $0.005 for a market cap of $93,905 plus FBEC is down 77.5% since last March and down 99.2% over the past five years according to Google Finance.
Top 10 Japanese Companies To Watch In Right Now: FutureFuel Corp. (FF)
FutureFuel Corp., through its subsidiary, FutureFuel Chemical Company, engages in the manufacture and sale of specialty chemicals and bio-based products primarily in the United States. The company operates in two segments, Chemicals and Biofuels. The Chemicals segment provides custom chemical manufacturing services for specific customers, such as bleach activators for detergent and consumer products manufacturers; proprietary herbicide and intermediates for life sciences companies; agrochemicals; and industrial and consumer products, such as cosmetics and personal care products, ink colorants, adhesion promoters, polymer additives, polymer and specialty dyes, specialty polymers, photographic and imaging chemicals, and food additives. This segment also manufactures and sells a range of performance chemicals, including a family of polymer (nylon) modifiers and small-volume specialty chemicals for various applications; a family of acetal-based solvents, consisting of diethoxy methane, dimethoxymethane, dibutoxymethane, and glycerol formal; and phenol sulfonic acid that build on sulfonations technology. Its chemical products are used in various markets and end uses, including detergents, agrochemicals, automotive, photographic imaging, coatings, nutrition, and polymer additives. The Biofuels segment produces and sells biodiesel, as well as petrodiesel in blends with or without biodiesel. This segment also operates a granary in central Arkansas that involves in the purchase and sale of agricultural commodities, primarily soybeans, rice, and corn. This segment markets its biodiesel products by truck and rail directly to customers. FutureFuel Corp. was formerly known as Viceroy Acquisition Corporation and changed its name to FutureFuel Corp. in 2006. FutureFuel Corp. was incorporated in 2005 and is based in St. Louis, Missouri.
Advisors' Opinion:- [By Monica Gerson]
FutureFuel (NYSE: FF) surged 21.01% to $21.25 in the pre-market session after the company reported a rise in its fourth-quarter earnings. FutureFuel posted its quarterly profit of $0.61 per share, versus a year-ago profit of $0.15 per share.
- [By Maxx Chatsko]
3. Focus on efficiency
A combination of factors plays a role in efficiently producing biodiesel. FutureFuel (NYSE: FF ) , which owns an annual capacity of 59 million gallons to complement its niche chemical business, relies heavily on location. The company's two biorefineries don't have a nationwide infrastructure to aid in getting product to the market and are dependent on rail and barge access. Despite the FutureFuel's amazing progress is improving its process -- annual capacity jumped from just 35 million gallons in 2011 to 59 million gallons today -- the company admits that its relatively small operations may cease to exist given changes in feedstock prices, government mandates, and tax credits. � - [By Brian Pacampara]
What: Shares of chemical and biofuels manufacturer FutureFuel (NYSE: FF ) soared 20% on Tuesday after its quarterly results impressed Wall Street.
Top 10 Japanese Companies To Watch In Right Now: Vision Industries Corp (VIIC)
Vision Industries Corp. (Vision), incorporated on May 11, 2004, is a manufacturer of zero-emission hydrogen fuel cell electric hybrid powered Class 8 trucks and terminal tractors. Vision operates in the short-haul, drayage trucking category (the movement of containerized cargo over a short distance, typically less than 50 miles, from a port to an intermodal facility, such as a rail yard). The Company�� products include the Tyrano, a short-haul Class 8 tractor, and the Zero-TT, a single axle terminal tractor co-developed with Cargotec USA, the maker of terminal tractors.
The Company markets its vehicles to drayage operators at the twin Ports of Los Angeles and Long Beach and plans to expand its target market nationally to all fleet operators, owner-operators and Original Equipment Manufacturers (OEMs). Vision aims to target drayage trucking fleet operators who operate in the eight deep-water ports (Los Angeles, Long Beach, Oakland, Seattle, Houston, Savanah, New York and New Jersey). Fleets which operate at these locations usually have predetermine routes, travel less than 50-mile (from Port to rail yard or distribution center) and have a return to base duty-cycle.
Tyrano
The Vision Tyrano is a lass 8 Zero-Emission Hydrogen Fuel Cell / Electric Hybrid heavy-duty truck designed to move containerized cargo from port to rail yard. With a GCVWR the Tyrano uses Lithium-ion batteries to power an electric motor and Hydrogen fuel cells to extend its range. The Vision Tyrano was designed for short-distance containerized cargo movement with trade corridor communities in mind.
Vision (Zero-TT) Terminal Tractors
The Zero-Emission Terminal Tractor (Zero-TT) is a Class 8 facility-only Hydrogen Fuel Cell Electric Hybrid vehicle. GCVWR and is designed to move the heavy containerized cargo inside a Port facility or central distribution center. The Zero-TT is designed to operate for two full eight-hour shifts with refillable hydrogen tanks.
The Cheetah Supercar is a zero-emission passenger sports car prototype. This sports car is using Vision�� hybrid hydrogen drive system which can deliver 425 horsepower and 1,350 feet /lbs of torque.
The Company competes with Bosch, Delphi, Siemens, Visteon, Quantum, Dynetek Industries Ltd., Lincoln Composites, Structural Composites Inc, Linde AG, Air Products and Energy Conversion Devices.
Advisors' Opinion:- [By Peter Graham]
Small cap green stocks Vision Industries Corp (OTCMKTS: VIIC), Bravo Enterprises Ltd (OTCMKTS: OGNG) and Kleangas Energy Technologies Inc (OTCMKTS: KGET) have reported recent news and/or they are being promoted. Of course, it goes without saying that small cap green stocks tend to be more volatile that other types of investments. So will investors and traders alike see some greenbacks from these green stocks? Here is a quick reality check:
Top 10 Japanese Companies To Watch In Right Now: AcelRx Pharmaceuticals Inc.(ACRX)
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain in the United States. The company develops ARX-01, a Sufentanil NanoTab PCA system, which completed Phase II clinical trial for acute post-operative pain. The Sufentanil NanoTab PCA system consists of sufentanil, a high therapeutic index opioid; NanoTabs, a non-invasive sublingual dosage form; and a handheld PCA device that enables simple patient-controlled delivery of NanoTabs in the hospital setting and eliminates the risk of programming errors. Its products also include ARX-02, a Sufentanil NanoTab BTP Management System that completed Phase II clinical trial for the treatment of cancer breakthrough pain; and ARX-03, a Sufentanil/Triazolam NanoTab, which completed Phase II clinical trial to provide mild sedation, anxiety reduction, and pain relief for patients undergoing painful procedures in a ph ysician?s office. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood, California.
Advisors' Opinion:- [By Roberto Pedone]
Another stock that insiders are jumping into here in a big way is AcelRx Pharmaceuticals (ACRX), which is involved in the development and commercialization of therapies for the treatment of acute and breakthrough pain. Insiders are buying this stock into major strength, since shares are up a whopping 177% so far in 2013.
AcelRx Pharmaceuticals has a market cap of $440 million and an enterprise value of $412 million. This stock trades at a premium valuation, with a price-to-sales of 145.48 and a price-to-book of 19.93. Its estimated growth rate for this year is 36.4%, and for next year it's pegged at 14.6%. This is a cash-rich company, since the total cash position on its balance sheet is $48.20 million and its total debt is $14.2 million.
A beneficial owner just bought 850,000 shares, or about $9.9 million worth of stock, at $11.65 per share.
From a technical perspective, ACRX is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares exploding higher from its low of $4.31 to its recent high of $13.50 a share. During that move, this stock has been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ACRX within range of triggering a major breakout trade.
If you're bullish on ACRX, then look for long-biased trades as long as this stock is trending some key near-term support levels at $11.46 to $11.43 a share or above its 50-day at $10.06, and then once it breaks out above some near-term overhead resistance levels at $12.57 to its all-time high at $13.50 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 637,219 shares. If that breakout hits soon, then ACRX will set up to enter new all-time-high territory above $13.50, which is bullish technical price action.
- [By Eric Volkman]
AcelRx (NASDAQ: ACRX ) has slapped a price tag on its recently announced common stock offering. The company's shares will be sold to the market in an underwritten public flotation at a cost of $11.65 apiece. The firm has also granted its underwriters a 30-day purchase option for up to an additional 570,000 shares.
- [By StockMatusow]
One company that had an offering received very well is AcelRx Pharmaceuticals (ACRX). AcelRx is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. On July 19, 2013, AcelRx offered 570,000 shares priced at $11.65. Investors aggressively bought the offering and the stock now sits at $11.96 per share. We covered AcelRx this year when it was about $6.50 per share. It reached highs since of $13.50, which effectively makes it more than a double.
Top 10 Japanese Companies To Watch In Right Now: Omnicell Inc.(OMCL)
Omnicell Inc. provides automated solutions for hospital medication and supply management primarily in the United States and Canada. The company offers medication use products, which include OmniRx that automates the management and dispensing of medications at the point of use; SinglePointe, a software product that controls medications on a patient-specific basis; AnywhereRN, a software that allows nurses to remotely operate automated dispensing cabinets; Pandora Analytics, a reporting and data analytics tool; and Savvy Mobile Medication System, a mobile platform for hospital information systems. Its medication use products also include OmniLinkRx, a software product that automates communication between nurses and the pharmacy; WorkflowRx, an automated storage, retrieval, inventory management, and repackaging solution; controlled substance barcode inventory management system; and Anesthesia Workstation, a secure dispensing system for the management of anesthesia supplies an d medications. In addition, the company provides medical and surgical supply products, which comprise Omnicell Supply Solution that automates the management and dispensing of medical and surgical supplies at the point of use; Supply/Rx Combination Solution, which manages medications and supplies in one versatile cabinet; Omnicell Tissue Center that manages the chain of custody for bone and tissue specimens; OptiFlex SS, which supplies modules for the perioperative areas; OptiFlex CL that supplies modules for the cardiac catheterization lab and other procedure areas; and OptiFlex MS, a system for the management of medical and surgical supplies. Further, it provides customer education and training, and maintenance and support services. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Omnicell (Nasdaq: OMCL ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Omnicell (Nasdaq: OMCL ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Omnicell doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 33.5%, and inventory increased 53.7%. Comparing the latest quarter to the prior-year quarter, the story looks potentially problematic. Revenue expanded 35.8%, and inventory increased 53.7%. Over the sequential quarterly period, the trend looks OK but not great. Revenue dropped 3.4%, and inventory dropped 2.9%.
No comments:
Post a Comment